In VivoDevice Transactions During the first quarter of 2016, device companies raised an aggregate $1.8 billion in financing, a 50% increase over last quarter's $1.2 billion. Debt was the top financing vehicl
ScripEncouraged by lessons learned from the 1990s genomics implosion and pharma's urgent need to re-invent the R&D process, some venture capitalists see renewed, albeit narrow opportunity in tool companies